Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Raloxifene and antiestrogenic gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem-like cells.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Raloxifene and antiestrogenic gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem-like cells.
Raloxifene and antiestrogenic gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem-like cells. Cancer Prev Res (Phila). 2014 Mar; 7(3):300-9.
View in:
PubMed
subject areas
Adenomatous Polyposis Coli Protein
Adenomatous Polyposis Coli Protein
Animals
Animals
Carcinogenesis
Carcinogenesis
Cell Count
Cell Count
Estrogen Antagonists
Estrogen Antagonists
Female
Female
Gonadotropin-Releasing Hormone
Gonadotropin-Releasing Hormone
Hematopoietic Stem Cells
Hematopoietic Stem Cells
Immunity, Cellular
Immunity, Cellular
Intestinal Neoplasms
Intestinal Neoplasms
Intestines
Intestines
Killer Cells, Natural
Killer Cells, Natural
Male
Male
Mice
Mice
Mice, Inbred C57BL
Mice, Inbred C57BL
Mice, Transgenic
Mice, Transgenic
Raloxifene Hydrochloride
Raloxifene Hydrochloride
Selective Estrogen Receptor Modulators
Selective Estrogen Receptor Modulators
authors with profiles
Hariprasad Gali